NS
Nirmal Sarma
About Nirmal Sarma
Data last updated:
Nirmal Sarma is a Director at Sushrua Hospitals Private Limited (since 2019). The company operates in Healthcare. Sushrua Hospitals Private Limited reported revenue of ₹14.15 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sushrua Hospitals Private Limited U85100AS2018PTC018650 | Director | 28 Feb 2019 | 2018 | ₹14.15 Cr (FY 2025) | Active |
Board colleagues of Nirmal Sarma
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gopal Kalita | 08194944 | Sushrua Hospitals Private Limited | Managing Director |
| Kumud Pathak | 08369286 | Sushrua Hospitals Private Limited | Director |
| Pradip Kumar Sarma | 05317984 | Sushrua Hospitals Private Limited | Director |
| Rajkamal Haloi | 08194932 | Sushrua Hospitals Private Limited | Director |
| Rupjyoti Kalita | 05318202 | Sushrua Hospitals Private Limited | Director |
| Swarupnath Sarma Basistha | 05317360 | Sushrua Hospitals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nirmal Sarma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirmal Sarma
Nirmal Sarma currently holds 1 directorship: Sushrua Hospitals Private Limited (Director, since 28 Feb 2019, revenue ₹14.15 Cr (FY 2025)).
Nirmal Sarma was first appointed on 28 Feb 2019 as Director at Sushrua Hospitals Private Limited.
The current boards of Nirmal Sarma's companies include Gopal Kalita (Sushrua Hospitals Private Limited), Kumud Pathak (Sushrua Hospitals Private Limited), Pradip Kumar Sarma (Sushrua Hospitals Private Limited), Rajkamal Haloi (Sushrua Hospitals Private Limited), Rupjyoti Kalita (Sushrua Hospitals Private Limited), Swarupnath Sarma Basistha (Sushrua Hospitals Private Limited).